CDT Equity Inc. Form SCHEDULE 13D/A — Oct 27, 2026
Corvus Capital Ltd., Manoira Corporation, and Dr. Andrew Regan filed Amendment No. 7 to their Schedule 13D on CDT Equity Inc. (formerly Conduit Pharmaceuticals), reporting Dr.
Key figures
- Shares Outstanding
- 9322805
- Regan shares
- 2064698
- Corvus shares
- 1565080
- Regan percent
- 22.1%
- Corvus percent
- 16.8%
- Manoira shares
- 1347619
- Manoira percent
- 14.5%
- Amendment number
- 7
- Share issue price
- $0.1447
- Severance amount usd
- 300000
- Severance shares issued
- 499616
- Shares issued to manoira
- 1347616
- Severance conversion price
- $0.1301
- Evaluation agreement fee usd
- 195000
- Severance shares converted usd
- 65000
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.